Erasca, Inc. Common Stock (ERAS) is a publicly traded Healthcare sector company. As of November 3, 2026, ERAS trades at $14.55 with a market cap of $5.02B and a P/E ratio of -36.15. ERAS moved +5.34% today. Year to date, ERAS is +290.84%; over the trailing twelve months it is +479.79%. Its 52-week range spans $1.01 to $24.28. Analyst consensus is buy with an average price target of $24.14. Rallies surfaces ERAS's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for ERAS, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $14.55 |
| Market Cap | $5.02B |
| P/E Ratio | -36.15 |
| EPS | $-0.44 |
| Dividend Yield | 0.00% |
| 52-Week High | $24.28 |
| 52-Week Low | $1.01 |
| Volume | 169.50K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-124.55M |
| Gross Margin | 0.00% |
7 analysts cover ERAS: 0 strong buy, 5 buy, 2 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $24.14.